The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
The global Radiopharmaceuticals market size is expected to reach US$ 11660 million by 2029, growing at a CAGR of 8.0% from 2023 to 2029. The market is mainly driven by the significant applications of Radiopharmaceuticals in various end use industries. The expanding demands from the Oncology, Cardiology and Other, are propelling Radiopharmaceuticals market. Diagnostic Radioisotopes, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Therapeutic Radioisotopes segment is estimated at % CAGR for the next seven-year period.
The major players in global Radiopharmaceuticals market include Bracco Imaging, Bayer, Mallinckrodt, etc. The top 3 players hold over 40% of global market shares. North America and Europe are main markets, they occupy over 70% of the global market. Diagnostic Radioisotopes is the main type, with a share about 90%. Oncology is the key application, which hold over 60% shares.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Radiopharmaceuticals, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Radiopharmaceuticals market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Radiopharmaceuticals market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Radiopharmaceuticals sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Radiopharmaceuticals covered in this report include Bracco Imaging, Bayer, Mallinckrodt, Nordion, Triad Isotopes, Lantheus, IBA Group, GE Healthcare and China Isotope & Radiation, etc.
The global Radiopharmaceuticals market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
- Bracco Imaging
- Bayer
- Mallinckrodt
- Nordion
- Triad Isotopes
- Lantheus
- IBA Group
- GE Healthcare
- China Isotope & Radiation
- Jubilant Pharma
- Eli Lilly
- Advanced Accelerator Applications
- SIEMENS
- Dongcheng
- Navidea
Global Radiopharmaceuticals market, by region:
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, UK, Italy, etc.)
- Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
- South America (Brazil, etc.)
- Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Radiopharmaceuticals market, Segment by Type:
- Diagnostic Radioisotopes
- Therapeutic Radioisotopes
Global Radiopharmaceuticals market, by Application
- Oncology
- Cardiology
- Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Radiopharmaceuticals manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Radiopharmaceuticals in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Radiopharmaceuticals Market Overview
1.1 Radiopharmaceuticals Product Overview
1.2 Radiopharmaceuticals Market Segment by Type
1.2.1 Diagnostic Radioisotopes
1.2.2 Therapeutic Radioisotopes
1.3 Global Radiopharmaceuticals Market Size by Type
1.3.1 Global Radiopharmaceuticals Market Size Overview by Type (2018-2029)
1.3.2 Global Radiopharmaceuticals Historic Market Size Review by Type (2018-2023)
1.3.3 Global Radiopharmaceuticals Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Radiopharmaceuticals Sales Breakdown by Type (2018-2023)
1.4.2 Europe Radiopharmaceuticals Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Radiopharmaceuticals Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Radiopharmaceuticals Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Radiopharmaceuticals Sales Breakdown by Type (2018-2023)
2 Global Radiopharmaceuticals Market Competition by Company
2.1 Global Top Players by Radiopharmaceuticals Sales (2018-2023)
2.2 Global Top Players by Radiopharmaceuticals Revenue (2018-2023)
2.3 Global Top Players by Radiopharmaceuticals Price (2018-2023)
2.4 Global Top Manufacturers Radiopharmaceuticals Manufacturing Base Distribution, Sales Area, Product Type
2.5 Radiopharmaceuticals Market Competitive Situation and Trends
2.5.1 Radiopharmaceuticals Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Radiopharmaceuticals Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Radiopharmaceuticals as of 2022)
2.7 Date of Key Manufacturers Enter into Radiopharmaceuticals Market
2.8 Key Manufacturers Radiopharmaceuticals Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Radiopharmaceuticals Status and Outlook by Region
3.1 Global Radiopharmaceuticals Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Radiopharmaceuticals Historic Market Size by Region
3.2.1 Global Radiopharmaceuticals Sales in Volume by Region (2018-2023)
3.2.2 Global Radiopharmaceuticals Sales in Value by Region (2018-2023)
3.2.3 Global Radiopharmaceuticals Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Radiopharmaceuticals Forecasted Market Size by Region
3.3.1 Global Radiopharmaceuticals Sales in Volume by Region (2024-2029)
3.3.2 Global Radiopharmaceuticals Sales in Value by Region (2024-2029)
3.3.3 Global Radiopharmaceuticals Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Radiopharmaceuticals by Application
4.1 Radiopharmaceuticals Market Segment by Application
4.1.1 Oncology
4.1.2 Cardiology
4.1.3 Other
4.2 Global Radiopharmaceuticals Market Size by Application
4.2.1 Global Radiopharmaceuticals Market Size Overview by Application (2018-2029)
4.2.2 Global Radiopharmaceuticals Historic Market Size Review by Application (2018-2023)
4.2.3 Global Radiopharmaceuticals Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Radiopharmaceuticals Sales Breakdown by Application (2018-2023)
4.3.2 Europe Radiopharmaceuticals Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Radiopharmaceuticals Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Radiopharmaceuticals Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Radiopharmaceuticals Sales Breakdown by Application (2018-2023)
5 North America Radiopharmaceuticals by Country
5.1 North America Radiopharmaceuticals Historic Market Size by Country
5.1.1 North America Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Radiopharmaceuticals Sales in Volume by Country (2018-2023)
5.1.3 North America Radiopharmaceuticals Sales in Value by Country (2018-2023)
5.2 North America Radiopharmaceuticals Forecasted Market Size by Country
5.2.1 North America Radiopharmaceuticals Sales in Volume by Country (2024-2029)
5.2.2 North America Radiopharmaceuticals Sales in Value by Country (2024-2029)
6 Europe Radiopharmaceuticals by Country
6.1 Europe Radiopharmaceuticals Historic Market Size by Country
6.1.1 Europe Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Radiopharmaceuticals Sales in Volume by Country (2018-2023)
6.1.3 Europe Radiopharmaceuticals Sales in Value by Country (2018-2023)
6.2 Europe Radiopharmaceuticals Forecasted Market Size by Country
6.2.1 Europe Radiopharmaceuticals Sales in Volume by Country (2024-2029)
6.2.2 Europe Radiopharmaceuticals Sales in Value by Country (2024-2029)
7 Asia-Pacific Radiopharmaceuticals by Region
7.1 Asia-Pacific Radiopharmaceuticals Historic Market Size by Region
7.1.1 Asia-Pacific Radiopharmaceuticals Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Radiopharmaceuticals Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Radiopharmaceuticals Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Radiopharmaceuticals Forecasted Market Size by Region
7.2.1 Asia-Pacific Radiopharmaceuticals Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Radiopharmaceuticals Sales in Value by Region (2024-2029)
8 Latin America Radiopharmaceuticals by Country
8.1 Latin America Radiopharmaceuticals Historic Market Size by Country
8.1.1 Latin America Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Radiopharmaceuticals Sales in Volume by Country (2018-2023)
8.1.3 Latin America Radiopharmaceuticals Sales in Value by Country (2018-2023)
8.2 Latin America Radiopharmaceuticals Forecasted Market Size by Country
8.2.1 Latin America Radiopharmaceuticals Sales in Volume by Country (2024-2029)
8.2.2 Latin America Radiopharmaceuticals Sales in Value by Country (2024-2029)
9 Middle East and Africa Radiopharmaceuticals by Country
9.1 Middle East and Africa Radiopharmaceuticals Historic Market Size by Country
9.1.1 Middle East and Africa Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Radiopharmaceuticals Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Radiopharmaceuticals Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Radiopharmaceuticals Forecasted Market Size by Country
9.2.1 Middle East and Africa Radiopharmaceuticals Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Radiopharmaceuticals Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Bracco Imaging
10.1.1 Bracco Imaging Company Information
10.1.2 Bracco Imaging Introduction and Business Overview
10.1.3 Bracco Imaging Radiopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Bracco Imaging Radiopharmaceuticals Products Offered
10.1.5 Bracco Imaging Recent Development
10.2 Bayer
10.2.1 Bayer Company Information
10.2.2 Bayer Introduction and Business Overview
10.2.3 Bayer Radiopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Bayer Radiopharmaceuticals Products Offered
10.2.5 Bayer Recent Development
10.3 Mallinckrodt
10.3.1 Mallinckrodt Company Information
10.3.2 Mallinckrodt Introduction and Business Overview
10.3.3 Mallinckrodt Radiopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Mallinckrodt Radiopharmaceuticals Products Offered
10.3.5 Mallinckrodt Recent Development
10.4 Nordion
10.4.1 Nordion Company Information
10.4.2 Nordion Introduction and Business Overview
10.4.3 Nordion Radiopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Nordion Radiopharmaceuticals Products Offered
10.4.5 Nordion Recent Development
10.5 Triad Isotopes
10.5.1 Triad Isotopes Company Information
10.5.2 Triad Isotopes Introduction and Business Overview
10.5.3 Triad Isotopes Radiopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Triad Isotopes Radiopharmaceuticals Products Offered
10.5.5 Triad Isotopes Recent Development
10.6 Lantheus
10.6.1 Lantheus Company Information
10.6.2 Lantheus Introduction and Business Overview
10.6.3 Lantheus Radiopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Lantheus Radiopharmaceuticals Products Offered
10.6.5 Lantheus Recent Development
10.7 IBA Group
10.7.1 IBA Group Company Information
10.7.2 IBA Group Introduction and Business Overview
10.7.3 IBA Group Radiopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
10.7.4 IBA Group Radiopharmaceuticals Products Offered
10.7.5 IBA Group Recent Development
10.8 GE Healthcare
10.8.1 GE Healthcare Company Information
10.8.2 GE Healthcare Introduction and Business Overview
10.8.3 GE Healthcare Radiopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
10.8.4 GE Healthcare Radiopharmaceuticals Products Offered
10.8.5 GE Healthcare Recent Development
10.9 China Isotope & Radiation
10.9.1 China Isotope & Radiation Company Information
10.9.2 China Isotope & Radiation Introduction and Business Overview
10.9.3 China Isotope & Radiation Radiopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
10.9.4 China Isotope & Radiation Radiopharmaceuticals Products Offered
10.9.5 China Isotope & Radiation Recent Development
10.10 Jubilant Pharma
10.10.1 Jubilant Pharma Company Information
10.10.2 Jubilant Pharma Introduction and Business Overview
10.10.3 Jubilant Pharma Radiopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Jubilant Pharma Radiopharmaceuticals Products Offered
10.10.5 Jubilant Pharma Recent Development
10.11 Eli Lilly
10.11.1 Eli Lilly Company Information
10.11.2 Eli Lilly Introduction and Business Overview
10.11.3 Eli Lilly Radiopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Eli Lilly Radiopharmaceuticals Products Offered
10.11.5 Eli Lilly Recent Development
10.12 Advanced Accelerator Applications
10.12.1 Advanced Accelerator Applications Company Information
10.12.2 Advanced Accelerator Applications Introduction and Business Overview
10.12.3 Advanced Accelerator Applications Radiopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Advanced Accelerator Applications Radiopharmaceuticals Products Offered
10.12.5 Advanced Accelerator Applications Recent Development
10.13 SIEMENS
10.13.1 SIEMENS Company Information
10.13.2 SIEMENS Introduction and Business Overview
10.13.3 SIEMENS Radiopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
10.13.4 SIEMENS Radiopharmaceuticals Products Offered
10.13.5 SIEMENS Recent Development
10.14 Dongcheng
10.14.1 Dongcheng Company Information
10.14.2 Dongcheng Introduction and Business Overview
10.14.3 Dongcheng Radiopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Dongcheng Radiopharmaceuticals Products Offered
10.14.5 Dongcheng Recent Development
10.15 Navidea
10.15.1 Navidea Company Information
10.15.2 Navidea Introduction and Business Overview
10.15.3 Navidea Radiopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Navidea Radiopharmaceuticals Products Offered
10.15.5 Navidea Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Radiopharmaceuticals Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Radiopharmaceuticals Industrial Chain Analysis
11.4 Radiopharmaceuticals Market Dynamics
11.4.1 Radiopharmaceuticals Industry Trends
11.4.2 Radiopharmaceuticals Market Drivers
11.4.3 Radiopharmaceuticals Market Challenges
11.4.4 Radiopharmaceuticals Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Radiopharmaceuticals Distributors
12.3 Radiopharmaceuticals Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
